| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 6.134 | 3.523 | 78 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 8 | 6.703 | 4.043 | 436 | 288 | 2.981 | 122 | 0 |
| Total Expenses - EUR | - | - | 11.948 | 59.428 | 42.198 | 7.345 | 6.662 | 21.546 | 7.719 | 10.980 |
| Gross Profit/Loss - EUR | - | - | -11.940 | -52.725 | -38.155 | -6.909 | -6.374 | -18.565 | -7.597 | -10.980 |
| Net Profit/Loss - EUR | - | - | -11.940 | -52.887 | -38.203 | -6.911 | -6.374 | -18.565 | -7.597 | -10.980 |
| Employees | - | - | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Miromed-Rom Group Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 27 | 122 | 296 | 290 | 284 | 285 | 284 | 282 |
| Current Assets | - | - | 2.122 | 14.282 | 16.875 | 17.396 | 18.153 | 22.613 | 19.805 | 11.885 |
| Inventories | - | - | 0 | 11.264 | 7.827 | 7.679 | 7.508 | 7.532 | 7.509 | 0 |
| Receivables | - | - | 0 | 2.642 | 8.183 | 8.953 | 9.628 | 12.932 | 12.168 | 11.682 |
| Cash | - | - | 2.122 | 376 | 864 | 754 | 1.007 | 2.140 | 118 | 193 |
| Shareholders Funds | - | - | -9.751 | -62.458 | -99.452 | -104.477 | -108.535 | -127.436 | -134.647 | -144.874 |
| Social Capital | - | - | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | 11.899 | 76.894 | 116.622 | 122.164 | 126.972 | 150.334 | 154.736 | 157.041 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Miromed-Rom Group Srl